Public health experts and environmentalists expressed alarm Thursday at the Environmental Protection Agency’s (EPA) recently announced cuts in enforcement of clean air and clean water
The FDA approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in adults with complement 3 glomerulopathy (C3G), the agency announced Thursday. “C3G is
Records from a university hospital in Japan suggested that people who went off oral anticoagulation 1 year after catheter ablation had increased thromboembolic risks in
The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn’s disease, drugmaker Johnson & Johnson announced on Thursday.
The 2025 Match cycle reached another all-time high with an increase of 4.1% applicants over last year’s record, the National Resident Matching Program (NRMP) reported
As measles cases in West Texas are still on the rise 2 months after the outbreak began, local public health officials say they expect the
Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis cardiomyopathy, as Alnylam Pharmaceuticals announced expanded FDA approval. Vutrisiran, a transthyretin-directed
[embedded content] Welcome to MedPage Today‘s “White Coat Chronicles,” a short-form feature series where we follow Emilie “Mia” Mathura, DO, MSPH, during her first year
Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults with psoriatic disease. Older systemic medications, including
A week has passed since federal agency leaders were supposed to submit plans for reductions-in-force (RIFs) and agency reorganizations, but workers at federal health agencies